Specialty Generics Market Growth, Trends, Absolute Opportunity and Value Chain 2017-2027 - Insurance News | InsuranceNewsNet

InsuranceNewsNet — Your Industry. One Source.™

Sign in
  • Subscribe
  • About
  • Advertise
  • Contact
Home Now reading Newswires
Topics
    • Advisor News
    • Annuity Index
    • Annuity News
    • Companies
    • Earnings
    • Fiduciary
    • From the Field: Expert Insights
    • Health/Employee Benefits
    • Insurance & Financial Fraud
    • INN Magazine
    • Insiders Only
    • Life Insurance News
    • Newswires
    • Property and Casualty
    • Regulation News
    • Sponsored Articles
    • Washington Wire
    • Videos
    • ———
    • About
    • Meet our Editorial Staff
    • Advertise
    • Contact
    • Newsletters
  • Exclusives
  • NewsWires
  • Magazine
  • Newsletters
Sign in or register to be an INNsider.
  • AdvisorNews
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Exclusives
  • INN Magazine
  • Insurtech
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Video
  • Washington Wire
  • Life Insurance
  • Annuities
  • Advisor
  • Health/Benefits
  • Property & Casualty
  • Insurtech
  • About
  • Advertise
  • Contact
  • Editorial Staff

Get Social

  • Facebook
  • X
  • LinkedIn
Newswires
Newswires RSS Get our newsletter
Order Prints
July 8, 2019 Newswires
Share
Share
Post
Email

Specialty Generics Market Growth, Trends, Absolute Opportunity and Value Chain 2017-2027

ReleaseWire

Valley Cottage, NY -- (SBWIRE) -- 07/08/2019 -- Specialty Generics are the generic versions of specialty pharmaceutical products. They are cost-effective when compared with specialty pharmaceuticals. Specialty generics include biopharmaceuticals, blood derived products and complex molecules.

Several blockbuster specialty drug molecules are coming off patent in the coming years. Hence, companies are foraying into this market to launch generic versions of the products by developing novel formulations. Additionally, global saturation of conventional generics market and low margins for generic drugs is also forcing companies to look for newer opportunities. However, commercialisation and development of specialty generics is more complex when compared with conventional generics products. Originator companies are adopting multiple strategies to hold on to specialty drug market share by mix of regulatory, commercial and product development strategies.

Download sample copy of this report:
https://www.futuremarketinsights.com/reports/sample/REP-GB-2955

Various companies are actively engaged in license, collaborations and acquisitions to expand their specialty generics capacities. For instance, in October 2016, Intellipharmaceutics entered into an exclusive license and supply agreement with Mallinckrodt to market, distribute, and sell its extended release drug product candidates in the U.S. market and to strengthen its specialty generics portfolio. Further, in October 2015, Teva Pharmaceutical Ltd. acquired Representaciones e Investigaciones Medicas, S.A. de C.V. (Rimsa) that involved in development specialty generic products, to enhance their sales in specialty generics market. In March 2016, County Line Pharmaceuticals —that involved in development of specialty generics —was acquired by Alvogen to boost its sales in U.S. market and increase its portfolio in specialty generics.

Specialty Generics Market: Drivers and Restraints

Favorable reimbursement policies, increasing prevalence of cancers, specialty drugs patent expiries, reforms enacted by government bodies, payer's pressures to reduce the drug prices, and lack of generic drugs to treat complex diseases are expected to boost demand for speciality generics during the forecast period. According to National Cancer Institute, 16 million cases of cancers are newly diagnosed every year in U.S. and 0.5 million deaths occur due to different type of cancers.

Development of speciality generics is a complex process and requires skilled workforce and sourcing of raw materials. These longstanding challenges can impede the growth of the market during the forecast period.

Specialty Generics Market: Segmentation

The global specialty generics market is classified on the basis of disease indication, route of administration, distribution channel, and geography.

Based on disease indication, the global specialty generics market is segmented into the following:

Based on route of administration, the global specialty generics market is segmented into the following:

Based on distribution channel, the global specialty generics market is segmented into the following:

Specialty Generics Market: Overview

Development of cost-effective drugs to treat oncology, multiple sclerosis and other infectious diseases can create significant opportunities for the specialty generics manufacturers. For instance, a patient has to spend around US$ 72,000 annually to treat multiple sclerosis conditions by using copaxone (Glatiramer). However, Novartis developed generic version of copaxone that costs only US$ 63,000. Hence, many insurance companies are showing interest to reimburse the specialty generics owing to their low cost. Based on disease indication, Oncology and Infectious diseases segment is expected to grow with a significant CAGR owing to increasing product patent expirations over the forecast period.

Specialty Generics Market: Regional Overview

Region-wise, the global specialty generics market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East and Africa. North America expected to dominate the global market for specialty generics due to favorable government policies and increasing specialty generic product launches over the forecast period. Large number of generic players and lack of specialty drugs in the Asia -Pacific market expected to boost the growth of the specialty generics market growth in APEJ region over the forecast period.

Buy Now to Get 10% Off and Free Customization as per Requirement:
https://www.futuremarketinsights.com/checkout/2955

Specialty Generics Market: Key Players

Some of the players in global specialty generics market include Valeant Pharmaceuticals International, Inc., Novartis,Pfizer Inc., Turing Pharmaceuticals, Teva Pharmaceutical Ltd., Mylan N.V.,Akorn, Inc., and Mallinckrodt

For more information on this press release visit: http://www.sbwire.com/press-releases/specialty-generics-market-growth-trends-absolute-opportunity-and-value-chain-2017-2027-1244163.htm

Media Relations Contact

Abhishek Budholiya
Manager
Future Market Insights
Telephone: 1-347-918-3531
Email: Click to Email Abhishek Budholiya
Web: https://www.futuremarketinsights.com

Older

Trump administration reviews human rights’ role in US policy

Newer

Mercury Insurance is a ‘Best Auto Insurance Company’ for 2019, According to Insure.com

Advisor News

  • The Gen Z money paradox
  • NAIFA applauds final SECURE 2.0 regulations
  • What will Democrats in Congress do about healthcare and retirement?
  • Election results cloud retirement legislation outlook, experts say
  • Planning for the missing chapter
More Advisor News

Annuity News

  • Best’s Market Segment Report: AM Best Maintains Stable Outlook on US Life/Annuity Insurance Segment
  • AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
  • Boomers want retirement protection, but their actions don’t match their mindset
  • NAIC task force to address LTC riders
  • ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
More Annuity News

Health/Employee Benefits News

  • New York Life Announces Record $3.1 Billion in Policy Owner Dividends for 2027
  • New Va. subsidies help lure people back to health insurance
  • 3 ways Crowley can make Healthcare more affordable in Wisconsin 3 ways to make healthcare more affordable in Wisconsin | Coleman Drake (Copy)
  • Vermont public schools expect the lowest health insurance increase in years. For districts, it’s only a small relief.
  • Vt. public schools expect the lowest health insurance increase in years
More Health/Employee Benefits News

Life Insurance News

  • Nebraska widow’s big win against life insurer in legal limbo
  • New York Life Announces Record $3.1 Billion in Policy Owner Dividends for 2027
  • AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
  • U-Haul Holding Company to Participate in Deutsche Bank Conference
  • NAIC task force to address LTC riders
More Life Insurance News

NEWS INSIDE

  • Companies
  • Earnings
  • Economic News
  • INN Magazine
  • Insurtech News
  • Newswires Feed
  • Regulation News
  • Washington Wire
  • Videos

FEATURED OFFERS

Press Releases

  • OpenRoad Insurance Data Shows 40% of Collector Vehicles Are Model Year 1980 or Newer
  • Insurvoice Lets Independent Insurance Agency Owners Analyze Every Customer Call in ChatGPT or Claude
  • Spectrum Weather & Specialty Insurance Celebrates 15 Years and Welcomes the Next Generation
  • Royal Neighbors of America® Increases Service Capacity
  • Benefits Studio Launches to Fill the Missing Middle of Benefits Navigation at $49/mo
More Press Releases > Add Your Press Release >

How to Write For InsuranceNewsNet

Find out how you can submit content for publishing on our website.
View Guidelines

Topics

  • Advisor News
  • Annuity Index
  • Annuity News
  • Companies
  • Earnings
  • Fiduciary
  • From the Field: Expert Insights
  • Health/Employee Benefits
  • Insurance & Financial Fraud
  • INN Magazine
  • Insiders Only
  • Life Insurance News
  • Newswires
  • Property and Casualty
  • Regulation News
  • Sponsored Articles
  • Washington Wire
  • Videos
  • ———
  • About
  • Meet our Editorial Staff
  • Advertise
  • Contact
  • Newsletters

Top Sections

  • AdvisorNews
  • Annuity News
  • Health/Employee Benefits News
  • InsuranceNewsNet Magazine
  • Life Insurance News
  • Property and Casualty News
  • Washington Wire

Our Company

  • About
  • Advertise
  • Contact
  • Meet our Editorial Staff
  • Magazine Subscription
  • Write for INN

Sign up for our FREE e-Newsletter!

Get breaking news, exclusive stories, and money- making insights straight into your inbox.

select Newsletter Options
Facebook Linkedin Twitter
© 2026 InsuranceNewsNet.com, Inc. All rights reserved.
  • Terms & Conditions
  • Privacy Policy
  • InsuranceNewsNet Magazine

Sign in with your Insider Pro Account

Not registered? Become an Insider Pro.